MedCath retires $102 million 9 7/8% notes with proceeds of loan

By Susanna Moon

Chicago, Nov. 14 - MedCath Corp. said it will repurchase all of its $102 million outstanding 9 7/8% senior notes using proceeds of a $75 million term loan and cash on hand.

The company also will pay the notes' repurchase premium of about $5 million.

Initial pricing for the loan, at MedCath's option, is either Libor plus 300 basis points or Bank of America's base rate plus 200 bps, according to the company's fourth-quarter earnings release.

"The facility allows MedCath to significantly reduce borrowing costs, fund previously announced growth capital requirements and selectively pursue hospital acquisitions or limited share repurchases," Jeff Hinton, MedCath's chief financial officer, said in the release.

MedCath is a Charlotte, N.C.-based health care provider focused on high-acuity services.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.